Phaseline

Targets › CGA

CGA (Glycoprotein hormones alpha chain): drug programs, companies and trials

2 programs from 2 companies in 2 trials: 1 Phase 3, 1 Phase 4; Genitourinary; next expected readout Dec 2027.

Shared alpha chain of the active heterodimeric glycoprotein hormones thyrotropin/thyroid stimulating hormone/TSH, lutropin/luteinizing hormone/LH, follitropin/follicle stimulating hormone/FSH and choriogonadotropin/CG. These hormones bind specific receptors on target cells that in turn activate downstream signaling pathways. (UniProt, P01215)

Open in Phaseline: the race on CGA, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Fertility Center of Las VegashCG injection
human chorionic gonadotropin - luteal phase support
CGA, CGBPhase 4Infertility (IVF Patients)Dec 2027
Kristine LoesslChoriongonadotropin alfa
Human chorionic gonadotropin (hCG) agonist
CGA, CGBPhase 3Infertility, FemaleMar 2028

Conditions

Infertility, Female (1) Infertility (IVF Patients) (1)

Modalities

small molecule (2)

Companies

Kristine Loessl (1) Fertility Center of Las Vegas (1)

Related targets

CGB (2)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.